Response of Serum Tumor Markers CA19-9 and bHCG to Cystectomy for Bladder Urothelial Carcinoma

Elyns Journal of Cancer Research
doi 10.19104/ejcr.2016.102
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elyns Group LLC

Related search

Comparison of Urinary and Serum CA 19-9 as Markers of Early Stage Urothelial Carcinoma

International braz j urol : official journal of the Brazilian Society of Urology
MedicineUrology
2013English

CEA and CA19-9 in Recurrence and in Monitoring Response in Gastric Carcinoma

journal of medical science and clinical research
2017English

Pre-Treatment Neutrophil-To-Lymphocyte Ratio as Predictor of Adverse Outcomes in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder

British Journal of Cancer
Cancer ResearchOncology
2014English

Clinicopathological Characteristics of ypT0N0 Urothelial Carcinoma Following Neoadjuvant Chemotherapy and Cystectomy

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2019English

Cadmium in Urothelial Carcinoma of the Bladder

Polish Journal of Pathology
MedicineForensic MedicinePathology
2014English

The Charlson Comorbidity Index Predicts Survival After Disease Recurrence in Patients Following Radical Cystectomy for Urothelial Carcinoma of the Bladder

Urologia Internationalis
Urology
2014English

Mex3a Expression and Survival Analysis of Bladder Urothelial Carcinoma

Oncotarget
Oncology
2017English

Bacillus Calmette–Guerin Immunotherapy for Urothelial Carcinoma of the Bladder

Immunotherapy
OncologyAllergyImmunology
2009English

Overexpression of RNF2 Is an Independent Predictor of Outcome in Patients With Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy

Scientific Reports
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy